Donepezil Hydrochloride

CHEMBL1678 Phase 4 Disetujui Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
416.0 g/mol
LogP
Phase
4

A hydrochloride salt form of donepezil used to treat mild to severe Alzheimer's disease. Like the base form, it works by preventing the breakdown of acetylcholine to improve memory and thinking.

Berat Molekul

416,0000 g/mol

TPSA

38,80 Ų

Area Terapeutik

Mekanisme Kerja

Reversible acetylcholinesterase inhibitor.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mekanisme

Reversible acetylcholinesterase inhibitor.

Struktur 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2.Cl

InChI

InChI=1S/C24H29NO3.ClH/c1-27-22-14-19-13-20(24(26)21(19)15-23(22)28-2)12-17-8-10-25(11-9-17)16-18-6-4-3-5-7-18;/h3-7,14-15,17,20H,8-13,16H2,1-2H3;1H

Molecular Formula

C24H30ClNO3

HBD / HBA

1 / 4

Ikatan yang Dapat Dirotasi

6

Atom Berat

29

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Pertanyaan yang Sering Diajukan

A hydrochloride salt form of donepezil used to treat mild to severe Alzheimer's disease. Like the base form, it works by preventing the breakdown of acetylcholine to improve memory and thinking.

Reversible acetylcholinesterase inhibitor.

Yes, Donepezil Hydrochloride is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1678. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 5741. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Penyangkalan Medis

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.